These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 14512433

  • 1. The anorexigenic fatty acid synthase inhibitor, C75, is a nonspecific neuronal activator.
    Takahashi KA, Smart JL, Liu H, Cone RD.
    Endocrinology; 2004 Jan; 145(1):184-93. PubMed ID: 14512433
    [Abstract] [Full Text] [Related]

  • 2. Effect of a fatty acid synthase inhibitor on food intake and expression of hypothalamic neuropeptides.
    Shimokawa T, Kumar MV, Lane MD.
    Proc Natl Acad Sci U S A; 2002 Jan 08; 99(1):66-71. PubMed ID: 11756683
    [Abstract] [Full Text] [Related]

  • 3. Effect of centrally administered C75, a fatty acid synthase inhibitor, on ghrelin secretion and its downstream effects.
    Hu Z, Cha SH, van Haasteren G, Wang J, Lane MD.
    Proc Natl Acad Sci U S A; 2005 Mar 15; 102(11):3972-7. PubMed ID: 15728730
    [Abstract] [Full Text] [Related]

  • 4. Effect of the anorectic fatty acid synthase inhibitor C75 on neuronal activity in the hypothalamus and brainstem.
    Gao S, Lane MD.
    Proc Natl Acad Sci U S A; 2003 May 13; 100(10):5628-33. PubMed ID: 12724522
    [Abstract] [Full Text] [Related]

  • 5. Differential effects of a centrally acting fatty acid synthase inhibitor in lean and obese mice.
    Kumar MV, Shimokawa T, Nagy TR, Lane MD.
    Proc Natl Acad Sci U S A; 2002 Feb 19; 99(4):1921-5. PubMed ID: 11854492
    [Abstract] [Full Text] [Related]

  • 6. Expression of FAS within hypothalamic neurons: a model for decreased food intake after C75 treatment.
    Kim EK, Miller I, Landree LE, Borisy-Rudin FF, Brown P, Tihan T, Townsend CA, Witters LA, Moran TH, Kuhajda FP, Ronnett GV.
    Am J Physiol Endocrinol Metab; 2002 Nov 19; 283(5):E867-79. PubMed ID: 12376313
    [Abstract] [Full Text] [Related]

  • 7. C75, a fatty acid synthase inhibitor, reduces food intake via hypothalamic AMP-activated protein kinase.
    Kim EK, Miller I, Aja S, Landree LE, Pinn M, McFadden J, Kuhajda FP, Moran TH, Ronnett GV.
    J Biol Chem; 2004 May 07; 279(19):19970-6. PubMed ID: 15028725
    [Abstract] [Full Text] [Related]

  • 8. Hypothalamic malonyl-CoA as a mediator of feeding behavior.
    Hu Z, Cha SH, Chohnan S, Lane MD.
    Proc Natl Acad Sci U S A; 2003 Oct 28; 100(22):12624-9. PubMed ID: 14532332
    [Abstract] [Full Text] [Related]

  • 9. Long-term effects of a fatty acid synthase inhibitor on obese mice: food intake, hypothalamic neuropeptides, and UCP3.
    Cha SH, Hu Z, Lane MD.
    Biochem Biophys Res Commun; 2004 Apr 30; 317(2):301-8. PubMed ID: 15063757
    [Abstract] [Full Text] [Related]

  • 10. C75 alters central and peripheral gene expression to reduce food intake and increase energy expenditure.
    Tu Y, Thupari JN, Kim EK, Pinn ML, Moran TH, Ronnett GV, Kuhajda FP.
    Endocrinology; 2005 Jan 30; 146(1):486-93. PubMed ID: 15498887
    [Abstract] [Full Text] [Related]

  • 11. The fatty acid synthase inhibitor cerulenin and feeding, like leptin, activate hypothalamic pro-opiomelanocortin (POMC) neurons.
    Shu IW, Lindenberg DL, Mizuno TM, Roberts JL, Mobbs CV.
    Brain Res; 2003 Sep 19; 985(1):1-12. PubMed ID: 12957363
    [Abstract] [Full Text] [Related]

  • 12. C75 increases peripheral energy utilization and fatty acid oxidation in diet-induced obesity.
    Thupari JN, Landree LE, Ronnett GV, Kuhajda FP.
    Proc Natl Acad Sci U S A; 2002 Jul 09; 99(14):9498-502. PubMed ID: 12060712
    [Abstract] [Full Text] [Related]

  • 13. The orexigenic activity of the hypothalamic neuropeptide 26RFa is mediated by the neuropeptide Y and proopiomelanocortin neurons of the arcuate nucleus.
    Lectez B, Jeandel L, El-Yamani FZ, Arthaud S, Alexandre D, Mardargent A, Jégou S, Mounien L, Bizet P, Magoul R, Anouar Y, Chartrel N.
    Endocrinology; 2009 May 09; 150(5):2342-50. PubMed ID: 19164468
    [Abstract] [Full Text] [Related]

  • 14. Apolipoprotein A-IV Inhibits AgRP/NPY Neurons and Activates Pro-Opiomelanocortin Neurons in the Arcuate Nucleus.
    Yan C, He Y, Xu Y, Shu G, Wang C, Yang Y, Saito K, Xu P, Hinton AO, Yan X, Yu L, Wu Q, Tso P, Tong Q, Xu Y.
    Neuroendocrinology; 2016 May 09; 103(5):476-488. PubMed ID: 26337236
    [Abstract] [Full Text] [Related]

  • 15. Ghrelin receptors mediate ghrelin-induced excitation of agouti-related protein/neuropeptide Y but not pro-opiomelanocortin neurons.
    Chen SR, Chen H, Zhou JJ, Pradhan G, Sun Y, Pan HL, Li DP.
    J Neurochem; 2017 Aug 09; 142(4):512-520. PubMed ID: 28547758
    [Abstract] [Full Text] [Related]

  • 16. Neuropeptide Y-mediated inhibition of proopiomelanocortin neurons in the arcuate nucleus shows enhanced desensitization in ob/ob mice.
    Roseberry AG, Liu H, Jackson AC, Cai X, Friedman JM.
    Neuron; 2004 Mar 04; 41(5):711-22. PubMed ID: 15003171
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Direct inhibition of arcuate proopiomelanocortin neurons: a potential mechanism for the orexigenic actions of dynorphin.
    Zhang X, van den Pol AN.
    J Physiol; 2013 Apr 01; 591(7):1731-47. PubMed ID: 23318874
    [Abstract] [Full Text] [Related]

  • 20. Pituitary adenylate cyclase-activating polypeptide inhibits food intake in mice through activation of the hypothalamic melanocortin system.
    Mounien L, Do Rego JC, Bizet P, Boutelet I, Gourcerol G, Fournier A, Brabet P, Costentin J, Vaudry H, Jégou S.
    Neuropsychopharmacology; 2009 Jan 01; 34(2):424-35. PubMed ID: 18536705
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.